Streetbeat News

CWBHF

Charlottes Web Holdings Inc

Industry

Medicinal and Botanical Manufacturing

Open

0.13

Mkt cap

20M

Volume

14K

High

0.14

P/E Ratio

-0.44

52-wk high

0.27

Low

0.13

Div yield

N/A

52-wk low

0.12

On December 21, 2023, several marijuana stocks experienced significant price movements. Notable gainers included Blueberries Medical, iAnthus Capital Holdings, and Heritage Cannabis Holding, with increases of 15.05%, 14.44%, and 12.73% respectively. Emeren Group, Corbus Pharmaceuticals, and Scotts Miracle Gro also saw their shares rise. Conversely, MJ Holdings, Khiron Life Sciences, and Item 9 Labs were among the biggest losers, with MJ Holdings dropping 30.41%. Other notable declines were observed in Eastside Distilling, Genetic Technologies, Canopy Growth, and Cresco Labs.

Portfolio Pulse from Benzinga Insights

December 21, 2023 | 9:30 pm

Cannabis stocks experienced significant movements on December 14, 2023. Genetic Technologies (GENE) saw a massive increase, closing up 474.82% at $3.15. Other gainers included Tilray Brands (TLRY), 22nd Century Group (XXII), Neptune Wellness Solns (NEPT), Mexco Energy (MXC), Emeren Group (SOL), and ESCO Technologies (ESE). Conversely, GrowGeneration (GRWG) and Greenlane Hldgs (GNLN) were among the losers, closing down 3.92% and 3.60% respectively.

Portfolio Pulse from Benzinga Insights

December 14, 2023 | 9:30 pm

MGO released its annual 'Cannabis 50' list, recognizing influential companies, organizations, and individuals in the cannabis and hemp sectors over the past five years. The list highlights the industry's progress and optimism for rescheduling cannabis. It includes companies like Charlotte’s Web Holdings, Cresco Labs, Curaleaf Holdings, and others. Athletes and entertainers are noted for mainstreaming the industry, and the list also acknowledges entities contributing to social progress and legislative reform.

Portfolio Pulse from Javier Hasse

December 14, 2023 | 5:55 pm

Charlotte's Web Holdings Inc (CWBHF) and AJNA BioSciences PBC, through their collaboration DeFloria LLC, have initiated the Phase 1 clinical trial of AJA001, a full-spectrum hemp botanical drug. The trial, which began in September, is the first human testing of the substance and aims to evaluate its safety, tolerability, and pharmacokinetics with about 64 participants in Brisbane, Australia. The successful initiation of the trial is seen as a critical milestone, and DeFloria plans to submit an Investigational New Drug application to the FDA for Phase 2 trials. CWBHF's stock was trading 5.95% higher at $0.2225 per share at the time of the report.

Portfolio Pulse from Patricio Liddle

December 13, 2023 | 4:23 pm

On December 12, 2023, several cannabis stocks experienced significant price movements. Mojave Brands, GrowLife, and Affinor Growers were among the top gainers, with Mojave Brands closing up over 101 million percent. Conversely, Choom Holdings and EVIO were among the top losers, both closing down 99%. Notable US-listed companies that saw price changes include Urban-gro, Corbus Pharmaceuticals, Cara Therapeutics, GrowGeneration, Canopy Growth, OrganiGram Holdings, Greenlane Holdings, and Aurora Cannabis.

Portfolio Pulse from Benzinga Insights

December 12, 2023 | 9:30 pm

On December 8, 2023, several marijuana stocks experienced significant price movements. EVIO led the gainers with a 4900% increase, while Choom Holdings saw the largest decline, dropping 75%. Other notable gainers include RIV Capital, GrowLife, and Canopy Growth, with increases of 40%, 40%, and 11.43% respectively. Among the losers, MGC Pharmaceuticals and Maple Leaf Green World fell by 16.24% and 13.49%. The movements reflect the volatile nature of the marijuana stock market.

Portfolio Pulse from Benzinga Insights

December 08, 2023 | 9:30 pm

On December 7, 2023, several marijuana stocks experienced significant price movements. Notable gainers included MPX International with a 9900% increase, while Maple Leaf Green World led the losers with a 20.32% decline. Other stocks such as CV Sciences, Global Compliance, and Psychemedics also saw gains, whereas Neptune Wellness Solutions and Greenlane Holdings were among those that fell.

Portfolio Pulse from Benzinga Insights

December 07, 2023 | 9:30 pm

The cannabis sector experienced significant movement on November 29, 2023, with a majority of listed companies showing gains. Notable gainers included Target Group, CNBX Pharmaceuticals, and 22nd Century Group, with increases of 84.14%, 63.64%, and 39.72% respectively. On the downside, AusCann Group Holdings, Item 9 Labs, and Pharmadrug saw their shares decline by 46.67%, 31.43%, and 21.58%. The movements reflect bullish sentiment in the cannabis space.

Portfolio Pulse from Benzinga Insights

November 29, 2023 | 9:30 pm

The cannabis sector experienced significant volatility on November 28, 2023, with notable gainers and losers among US-listed stocks. GrowLife (PHOT) saw an extraordinary rise of 900%, while Global Hemp Group (GBHPF) led the losers with a 57.50% decline. Other notable movers included CLS Holdings USA (CLSH), Corbus Pharmaceuticals (CRBP), and SNDL Inc. (SNDL), with substantial percentage changes in their stock prices.

Portfolio Pulse from Benzinga Insights

November 28, 2023 | 9:30 pm

On November 27, 2023, several cannabis stocks experienced significant price movements. EVIO led the gainers with a 9900.00% increase, while Cann Gr topped the losers with a 27.38% decline. Notable gainers included AusCann Group, Global Compliance, and Item 9 Labs, with increases of 212.50%, 66.67%, and 39.13% respectively. Among the losers, Rocky Mountain High, 1933 Industries, and iAnthus Capital Holdings saw declines of 21.21%, 15.00%, and 9.37%. Corbus Pharmaceuticals and Cara Therapeutics were notable NASDAQ-listed companies with gains and losses of 15.21% and 5.11% respectively.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 9:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.